Federal award
SYNERGENE THERAPEUTICS INC
HDTRA120C0045
ContractSBIR/STTR ST3
Obligated and Ceiling
- Obligated (net)
- $7,589,343.79
- Ceiling (potential value, not spending)
- $12,202,250.58
- Current value
- $7,589,343.79
- Gross positive obligations
- $7,589,343.79
Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.
Award Details
- Recipient
- SYNERGENE THERAPEUTICS INC · W8E3G5851JK4
- Owner company
- Not a reviewed companyNo reviewed company owns this recipient.
- Reported parent
- SYNERGENE THERAPEUTICS INC · WY76BLRBNNN7
- Awarding agency
- Department of War · sub-agency 9761 · office HDTRA1
- Funding agency
- Department of War · sub-agency 9761
- Product or service (PSC)
- AD92 · R&D- DEFENSE OTHER: OTHER (APPLIED RESEARCH/EXPLORATORY DEVELOPMENT)
- Industry (NAICS)
- 541714 · RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)
- PIID
- HDTRA120C0045
- Award type code
- D
- Actions
- 13 · Jul 6, 2020 to Feb 11, 2025
- Why it is listed
- gross positive obligations of $100k or more (contracts); SBIR/STTR award
Action History13
| Date | FY | Mod | Action type | Obligation | Company in company totals |
|---|---|---|---|---|---|
| Feb 11, 2025 | FY2025 | P00012 | C | $706,655.10 | — |
| Jul 3, 2024 | FY2024 | P00011 | G | $784,690.69 | — |
| Apr 18, 2024 | FY2024 | P00010 | C | $688,893.55 | — |
| Feb 29, 2024 | FY2024 | P00009 | C | $100,000.00 | — |
| Dec 22, 2023 | FY2024 | P00008 | B | $50,104.35 | — |
| Jul 6, 2023 | FY2023 | P00007 | G | $600,000.00 | — |
| Jul 5, 2023 | FY2023 | P00006 | B | $0.00 | — |
| May 15, 2023 | FY2023 | P00005 | C | $735,091.53 | — |
| Apr 27, 2022 | FY2022 | P00004 | A | $772,667.87 | — |
| Jun 3, 2021 | FY2021 | P00003 | C | $700,000.00 | — |
| Mar 31, 2021 | FY2021 | P00002 | C | $1,107,692.76 | — |
| Dec 2, 2020 | FY2021 | P00001 | C | $343,547.94 | — |
| Jul 6, 2020 | FY2020 | 0 | — | $1,000,000.00 | — |
Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.